Skip to main content

Scott Haden Kollins, PhD

Professor in Psychiatry and Behavioral Sciences
Professor of Psychology and Neuroscience
Division: 
Addiction
Category: 
Office: 2608 Erwin Road Lakeview Pavi, Durham, NC 27705
Campus Mail: DUMC Box 3527 Med Ctr, Durham, NC 27710

Scott H. Kollins, PhD received his undergraduate degree in psychology from Duke and his Master’s and Doctorate degrees in Clinical Psychology from Auburn University. After completing his clinical internship at the University of Mississippi Medical Center, where he served as Chief Intern, he joined the faculty of the Department of Psychology at Western Michigan University for three years, before joining the Duke faculty in 2000. Dr. Kollins has published more than 125 scientific papers in peer-reviewed journals.  Over the past 10 years, his research has been supported by 6 different federal agencies, including NICHD, NIDA, NIMH, NIEHS, NINDS, and EPA, and he currently holds a mid-career K24 award from NIDA.  He has also served as PI on more than 40 industry-funded clinical trials and is a consultant to a number of pharmaceutical companies in the area of ADHD clinical psychopharmacology.  He has served as a standing member of the Child Psychopathology and Developmental Disabilities study section and also served as an ad-hoc reviewer for 10 additional NIH study sections and 7 international granting agencies. He is an Associate Editor for the Journal of Attention Disorders and has reviewed for more than 50 different peer-reviewed journals. He is an elected member of the College on Problems of Drug Dependence and the American College of Neuropsychopharmacology. Dr. Kollins is a licensed clinical psychologist and maintains a practice through the ADHD Program’s outpatient clinic. His research interests are in the areas of psychopharmacology and the intersection of ADHD and substance abuse, particularly cigarette smoking.

Education and Training

  • Ph.D., Auburn University, 1997

Selected Grants

Publications

Mitchell, John T., Naomi Ornstein Davis, Scott H. Kollins, and Jessica R. Lunsford-Avery. “Sluggish cognitive tempo (SCT) in an adult outpatient sample seeking an attention-deficit/hyperactivity disorder assessment: Age of onset and assessment method impact on SCT rates.” J Psychiatr Res 131 (December 2020): 203–8. https://doi.org/10.1016/j.jpsychires.2020.09.013.

Full Text

Engelhard, Matthew M., Samuel I. Berchuck, Jyotsna Garg, Ricardo Henao, Andrew Olson, Shelley Rusincovitch, Geraldine Dawson, and Scott H. Kollins. “Health system utilization before age 1 among children later diagnosed with autism or ADHD.” Sci Rep 10, no. 1 (October 19, 2020): 17677. https://doi.org/10.1038/s41598-020-74458-2.

Full Text

Addicott, Merideth A., John M. Pearson, Julia C. Schechter, Jeffrey J. Sapyta, Margaret D. Weiss, and Scott H. Kollins. “Attention-deficit/hyperactivity disorder and the explore/exploit trade-off.” Neuropsychopharmacology, October 11, 2020. https://doi.org/10.1038/s41386-020-00881-8.

Full Text

Lunsford-Avery, Jessica R., Maggie M. Sweitzer, Scott H. Kollins, and John T. Mitchell. “Eveningness Diurnal Preference: Putting the "Sluggish" in Sluggish Cognitive Tempo.” J Atten Disord, October 7, 2020, 1087054720959697. https://doi.org/10.1177/1087054720959697.

Full Text

Adjei, Akwete L., Inder Chaudhary, Scott H. Kollins, and Americo Padilla. “A Pharmacokinetic Study of Methylphenidate Hydrochloride Multilayer Extended-Release Capsules (Aptensio XR®) in Preschool-Aged Children with Attention-Deficit/Hyperactivity Disorder.” Paediatr Drugs 22, no. 5 (October 2020): 561–70. https://doi.org/10.1007/s40272-020-00409-z.

Full Text

Lunsford-Avery, Jessica R., Casey Keller, Scott H. Kollins, Andrew D. Krystal, Leah Jackson, and Matthew M. Engelhard. “Feasibility and Acceptability of Wearable Sleep Electroencephalogram Device Use in Adolescents: Observational Study.” Jmir Mhealth Uhealth 8, no. 10 (October 1, 2020): e20590. https://doi.org/10.2196/20590.

Full Text

Fuemmeler, Bernard F., Yaou Sheng, Julia C. Schechter, Elizabeth Do, Nancy Zucker, Alesha Majors, Rachel Maguire, Susan K. Murphy, Cathrine Hoyo, and Scott H. Kollins. “Associations between attention deficit hyperactivity disorder symptoms and eating behaviors in early childhood.” Pediatr Obes 15, no. 7 (July 2020): e12631. https://doi.org/10.1111/ijpo.12631.

Full Text

Kollins, S. H., D. J. DeLoss, E. Cañadas, J. Lutz, R. L. Findling, R. S. E. Keefe, J. N. Epstein, A. J. Cutler, and S. V. Faraone. “A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial.” The Lancet Digital Health 2, no. 4 (April 1, 2020): e168–78. https://doi.org/10.1016/S2589-7500(20)30017-0.

Full Text

Kollins, Scott H., Maggie M. Sweitzer, F Joseph McClernon, and Kenneth A. Perkins. “Increased subjective and reinforcing effects of initial nicotine exposure in young adults with attention deficit hyperactivity disorder (ADHD) compared to matched peers: results from an experimental model of first-time tobacco use.” Neuropsychopharmacology 45, no. 5 (April 2020): 851–56. https://doi.org/10.1038/s41386-019-0581-7.

Full Text

Childress, Ann C., Robert L. Findling, James Wu, Scott H. Kollins, Yi Wang, Patrick Martin, and Brigitte Robertson. “Lisdexamfetamine Dimesylate for Preschool Children with Attention-Deficit/Hyperactivity Disorder.” J Child Adolesc Psychopharmacol 30, no. 3 (April 2020): 128–36. https://doi.org/10.1089/cap.2019.0117.

Full Text

Pages